Rafael Botella-Estrada Selected Research

Rafael Botella-Estrada Research Topics

Disease

13	Melanoma (Melanoma, Malignant) 01/2018 - 01/2005
6	Basal Cell Carcinoma (Rodent Ulcer) 03/2023 - 01/2015
5	Neoplasms (Cancer) 12/2021 - 02/2009
3	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2022 - 07/2020
3	Skin Neoplasms (Skin Cancer) 06/2017 - 01/2015
2	Atopic Dermatitis (Atopic Eczema) 01/2024 - 11/2023
2	Actinic Keratosis 11/2023 - 04/2012
2	Neoplasm Metastasis (Metastasis) 07/2015 - 10/2005
2	Nevus (Nevi) 10/2008 - 06/2006
1	Chikungunya Fever 03/2024
1	Cutaneous Lupus Erythematosus 01/2024
1	Photosensitivity Disorders (Photodermatitis) 03/2023
1	Warts (Wart) 03/2023
1	Foreign-Body Reaction 01/2023
1	Leishmaniasis 01/2023
1	Dermatomyositis (Dermatopolymyositis) 10/2022
1	Inflammation (Inflammations) 10/2022
1	Erythema Nodosum 01/2022
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2021
1	COVID-19 02/2021
1	Dermatofibrosarcoma 01/2021
1	Lymphomatoid Papulosis 04/2020
1	Hypereosinophilic Syndrome (Loeffler Endocarditis) 04/2020
1	Basosquamous Carcinoma 09/2019
1	Cicatrix (Scar) 01/2018
1	Halo Nevus 05/2015
1	Dermatitis 06/2011
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 02/2009
1	Lung Neoplasms (Lung Cancer) 02/2009
1	Spindle Cell Nevus 10/2008
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 06/2006
1	Pigmented Nevus (Melanocytic Nevus) 06/2006
1	Port-Wine Stain (Nevus Flammeus) 12/2004

Drug/Important Bio-Agent (IBA)

2	dupilumabIBA 01/2024 - 11/2023
2	apremilastIBA 01/2022 - 07/2020
2	ParaffinIBA 01/2021 - 08/2014
2	Imiquimod (Aldara)FDA LinkGeneric 04/2012 - 10/2005
2	DNA (Deoxyribonucleic Acid)IBA 09/2010 - 10/2009
2	Type 1 Melanocortin ReceptorIBA 08/2010 - 10/2009
2	CytokinesIBA 04/2005 - 01/2005
1	anifrolumabIBA 01/2024
1	tralokinumabIBA 11/2023
1	Ointments (Pastes)IBA 11/2023
1	tirbanibulinIBA 11/2023
1	Photosensitizing Agents (Photosensitizers)IBA 03/2023
1	Furocoumarins (Furanocoumarins)IBA 03/2023
1	LatexIBA 03/2023
1	Meglumine AntimoniateIBA 01/2023
1	SiliconesIBA 01/2023
1	Mi-2 antibodiesIBA 10/2022
1	CollagenIBA 10/2022
1	InterferonsIBA 12/2021
1	Acitretin FDA Link 07/2020
1	Methotrexate (Mexate)FDA LinkGeneric 07/2020
1	Ustekinumab (CNTO 1275)FDA Link 07/2020
1	Infliximab (Remicade)FDA Link 07/2020
1	Adalimumab (Humira)FDA Link 07/2020
1	Etanercept (Enbrel)FDA Link 07/2020
1	secukinumabIBA 07/2020
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 07/2020
1	Imatinib Mesylate (Gleevec)FDA Link 04/2020
1	HhAntag691IBA 09/2019
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2018
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 07/2015
1	Protein Isoforms (Isoforms)IBA 07/2015
1	Granzymes (Granzyme)IBA 05/2015
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 04/2012
1	liposomal doxorubicin (Doxil)FDA Link 06/2011
1	Tumor Suppressor Protein p14ARF (p14ARF)IBA 10/2009
1	ORALIT (ORS)IBA 02/2009
1	Melanins (Melanin)IBA 10/2008
1	Indicators and Reagents (Reagents)IBA 12/2005
1	Proteins (Proteins, Gene)FDA Link 01/2005
1	Interleukin-10 (Interleukin 10)IBA 01/2005
1	IonomycinIBA 01/2005

Therapy/Procedure

5	Brachytherapy 06/2017 - 01/2015
4	Mohs Surgery (Mohs' Micrographic Surgery) 03/2023 - 03/2020
4	Therapeutics 02/2021 - 12/2004
2	Biological Therapy 01/2023 - 07/2020
2	Radiotherapy 06/2017 - 01/2015
2	Drug Therapy (Chemotherapy) 06/2011 - 06/2006
1	Tourniquets 03/2024
1	Drug Tapering 01/2024
1	Traditional Medicine (Folk Remedies) 03/2023
1	Hematopoietic Stem Cell Transplantation 01/2023
1	Tattooing 12/2022
1	Sutures (Suture) 01/2018
1	Photochemotherapy (Photodynamic Therapy) 04/2012
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 06/2011
1	Dye Lasers 12/2004